C5orf23 Inhibitors
C5orf23 inhibitors encompass a diverse array of chemical compounds that target specific signaling pathways and biological processes to reduce the functional activity of C5orf23. These inhibitors operate primarily through interference with kinase signaling cascades, which are integral to C5orf23's role in cellular metabolism, growth, and stress response. For instance, certain inhibitors target the mTOR pathway, a central regulator of cell growth, and by doing so, they suppress the metabolic and proliferative processes that C5orf23 influences. Other compounds engage with the PI3K/Akt and MAPK/ERK pathways, which are pivotal for cell survival and differentiation. By halting the function of key kinases within these pathways, these inhibitors curtail the downstream signaling events that would otherwise enhance the activity of C5orf23, leading to a comprehensive diminution of its role in cellular proliferation and survival.
Moreover, the inhibitors' spectrum includes molecules that hinder the action of specific protein kinases such as RAF-1, MEK, JNK, and CK2, which are all implicated in the regulatory network wherein C5orf23 is a participant. The inhibition of RAF-1 and MEK, for example, results in a substantial decrease in ERK/MAPK signaling, attenuating the contributions of C5orf23 to cell growth signaling. In addition, by obstructing the activity of JNK, involved in stress response and apoptosis, and CK2, which plays a role in various cellular functions, the inhibitors ensure a thorough suppression of the pathways pertinent to C5orf23's activity. Similarly, compounds that inhibit ROCK disrupt the Rho/ROCK pathway crucial for maintaining cellular architecture and motility, further indicating the breadth of the inhibitory mechanisms at play.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that suppresses cell growth and proliferation. Since C5orf23 is involved in cellular metabolism and growth, the inhibition of mTOR by Rapamycin leads to a decrease in the processes that C5orf23 is implicated in, thereby inhibiting C5orf23's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that disrupts phosphatidylinositol 3-kinase signaling, which is vital for many cellular processes including the ones regulated by C5orf23. By inhibiting PI3K, LY 294002 causes a reduction in the downstream effects on cellular growth and survival, thereby diminishing C5orf23's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that blocks the p38 mitogen-activated protein kinases pathway. Given that C5orf23 is associated with cellular response to stress, the inhibition of this pathway by SB 203580 would lead to an impediment in stress response signaling where C5orf23 is a factor, resulting in its functional inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK pathway inhibitor that impedes the MAPK/ERK pathway. As C5orf23 is involved in the regulation of cellular differentiation and proliferation, the inhibition of this pathway by PD 98059 would lead to a reduction in these processes that are part of C5orf23’s functional repertoire, thus indirectly inhibiting C5orf23. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK signaling pathways. C5orf23, being a regulator in these pathways, would be affected by the inhibition of JNK activity, resulting in a decrease in C5orf23-mediated signaling and a consequent reduction in its functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K/Akt signaling pathway inhibitor that targets phosphoinositide 3-kinases. C5orf23, which plays a role in the PI3K/Akt pathway, is affected by the inhibition of this pathway, leading to a decrease in cellular survival signals and thus, a reduction in C5orf23 activity. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
A specific inhibitor of RAF-1 kinase, which indirectly affects the ERK/MAPK signaling pathway. As C5orf23 is implicated in signaling through this pathway, inhibition of RAF-1 by ZM 336372 would lead to reduced signaling through ERK/MAPK, thereby decreasing the functional activity of C5orf23. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
A specific Akt inhibitor that hampers the PI3K/Akt pathway. Since C5orf23 is part of the regulatory process within this pathway, the inhibition of Akt by Triciribine would lead to a decrease in the survival and proliferation signals that C5orf23 is associated with, thereby inhibiting its functional activity. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
A flavonoid that inhibits CK2, a protein kinase involved in various cellular processes. C5orf23, associated with pathways regulated by CK2, would experience a decrease in its activity due to the inhibition of CK2 by Apigenin, leading to a reduction in C5orf23's functional influence in these processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor. If C5orf23 plays a role in cytoskeletal rearrangements, Y-27632 inhibition of ROCK would consequently impede C5orf23's activity. | ||||||